Results 61 to 70 of about 1,274,904 (321)

Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department [PDF]

open access: yes, 2020
As of March 30th, 2020 there were 161,807 total cases and 2,953 total deaths of SARS-CoV-2 in the United States, with the number of cases expected to rise.
Brown, Cortlyn   +2 more
core  

Droplet evaporation residue indicating SARS-COV-2 survivability on surfaces

open access: yes, 2020
SARS-CoV-2 survives and remains viable on surfaces for several days under different environments as reported in recent studies. However, it is unclear how the viruses survive for such a long time and why their survivability varies across different ...
He, Zilong   +5 more
core   +1 more source

Fractional-order susceptible-infected model: definition and applications to the study of COVID-19 main protease [PDF]

open access: yes, 2020
We propose a model for the transmission of perturbations across the amino acids of a protein represented as an interaction network. The dynamics consists of a Susceptible-Infected (SI) model based on the Caputo fractional-order derivative.
Abadias, Luciano   +2 more
core   +2 more sources

Cell entry mechanisms of SARS-CoV-2

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2020
Significance A key to curbing SARS-CoV-2 is to understand how it enters cells. SARS-CoV-2 and SARS-CoV both use human ACE2 as entry receptor and human proteases as entry activators.
J. Shang   +6 more
semanticscholar   +1 more source

Reliable and accurate diagnostics from highly multiplexed sequencing assays [PDF]

open access: yes, 2020
Scalable, inexpensive, and secure testing for SARS-CoV-2 infection is crucial for control of the novel coronavirus pandemic. Recently developed highly multiplexed sequencing assays (HMSAs) that rely on high-throughput sequencing can, in principle, meet ...
Bloom, Joshua S.   +8 more
core  

Coronavirus biology and replication: implications for SARS-CoV-2

open access: yesNature Reviews Microbiology, 2020
The SARS-CoV-2 pandemic and its unprecedented global societal and economic disruptive impact has marked the third zoonotic introduction of a highly pathogenic coronavirus into the human population.
P. V’kovski   +4 more
semanticscholar   +1 more source

Erythema Multiforme Major following SARS‐CoV‐2 vaccine

open access: yesClinical Case Reports, 2021
Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2.
Alberto Maria Saibene   +7 more
doaj   +1 more source

Electronic Health Record-Based Surveillance for Community Transmitted COVID-19 in the Emergency Department [PDF]

open access: yes, 2020
Introduction: SARS-CoV-2, a novel coronavirus, manifests as a respiratory syndrome (COVID-19) and is the cause of an ongoing pandemic. The response to COVID-19 in the United States has been hampered by an overall lack of diagnostic testing capacity.
Barclay-Buchanan, Ciara   +8 more
core  

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

open access: yesNature Microbiology, 2020
Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered
M. Letko, A. Marzi, V. Munster
semanticscholar   +1 more source

SARS-CoV-2 surveillance in a hospital and control of an outbreak on a geriatric ward using whole genome sequencing

open access: yesInfection Prevention in Practice
Summary: Background: During the SARS-CoV-2 pandemic, dominant viral variants were repeatedly replaced by new variants with altered properties, frequently changing the dynamics of the infection event, as well as the effectiveness of vaccines and ...
Hanno Schmidt   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy